NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
0
Open gap and secondary test. I like this long at $344.48

No position

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.